How to embrace the opportunity?
Unprecedented changes are ahead of us: artificial intelligence, the internet of things, big data, and social and commercial networks are radically changing the way we live and do business, and the impact of these changes will go above and beyond the 1990s experiments with the dot-com wave.
The life sciences Industry is well positioned to take advantage of these changes, as leading companies have successfully overcome patent cliffs with innovative products, and new generations of drugs are being profiled to address unmet needs in a variety of disease areas. An invaluable set of opportunities lies ahead.
Innovation, growth, and science are at the heart of Arthur D. Littles DNA. In the last decades ADL has advised dozens of life sciences companies on strategic opportunities, with special focus on innovation, growth, and addressing functional issues in a creative way. In the following pages, we share our perspective on some of these opportunities and their associated challenges. We hope you will find these stimulating, and look forward to discussing our experience further with you.
Released: January 2017
Download File ADL_HC_BrochureEuropeanVersion_01.pdf (.PDF, 6.4 MB)
« previous report | next report »